KYRIX Trademark
KYRIX is a USPTO trademark filed by Bridge Biotherapeutics Inc.. Status: Pending.
Trademark Facts
| Mark | KYRIX |
|---|---|
| Serial Number | 97411368 |
| Status | Pending |
| Filing Date | 2022-05-15 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | Bridge Biotherapeutics Inc. |
| Attorney of Record | Timur Slonim |
| Prosecution Events | 32 |
| Latest Event | EX1G on 2025-12-17 |
Goods & Services
Pharmaceutical and biopharmaceutical preparations, excluding vaccines for human use, for the treatment and prevention of cancer, fibrosis, and inflammatory diseases for therapeutical applications excluding prescription pharmaceutical and medicinal preparations for the treatment and prevention of kidney diseases and disorders, administered in any way other than topically, and excluding anti-inflammatories; Pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical drug discovery services; pharmaceutical and biopharmaceutical research services
Recent Prosecution Activity
| Date | Code | Type | Description |
|---|---|---|---|
| 2025-12-17 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2025-12-17 | EX1G | S | SOU EXTENSION 1 GRANTED |
| 2025-12-17 | EXT1 | S | SOU EXTENSION 1 FILED |
| 2025-12-17 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| 2025-06-17 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2025-05-11 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| 2025-04-11 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED |
| 2025-04-11 | APET | A | ASSIGNED TO PETITION STAFF |
| 2025-03-07 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 2025-01-23 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED |
Other Trademarks from Bridge Biotherapeutics Inc.
Bridge Biotherapeutics Inc. owns 3 USPTO trademarks (0 live).
- SELECTIVITY AND REACTIVITY TUNING — Abandoned (filed 2023-04-19)
- START — Abandoned (filed 2023-04-19)
- PRECISION MEDICINE THROUGH NOVEL COVALENCY — Abandoned (filed 2023-04-19)
Nice Class Context
- Class 005 (Pharmaceuticals) — 182960 live marks in this class
- Class 042 (Software & IT) — 352450 live marks in this class